Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Investigation of Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Sponsor: Mayo Clinic
Terminated
Low/slow accrual
Other terminated trials from Mayo Clinic
Other Bladder Cancer trials with similar outcome
A observational or N/A phase clinical study on Bladder Cancer and Bladder Carcinoma, this trial is terminated or withdrawn. The trial is conducted by Mayo Clinic and has accumulated 8 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
May 2025 — Present [monthly]
Terminated
Status: Suspended → Terminated
-
Dec 2024 — May 2025 [monthly]
Suspended
Status: Recruiting → Suspended
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Dec 2023 — Jun 2024 [monthly]
Recruiting
-
Jul 2023 — Dec 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2023 — Jul 2023 [monthly]
Not Yet Recruiting
First recorded
Apr 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .